Corporate executives, the management consultants who advise them, and the financial industry executives who help corporations finance their capital investments tend to believe that whenever their joint work enhances the wealth of a firm’s shareholders
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/06/01/value-creation-and-value-shifting-in-health-care/
Posted
Jun 01 2016, 11:00 AM
by
Health Affairs BlogHealth Affairs Blog
Filed under: Quality, Population Health, Payment Policy, Costs and Spending, Equity and Disparities, Drugs and Medical Technology, Sovaldi, Big Pharma, economics, Turing Pharmaceuticals, drug pricing, Valeant Pharmaceuticals